Study S001920

Impact of Exenatide on Sleep and Circadian Function in Type 2 Diabetes: A Pilot Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01136798
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: QUADRUPLE
Status: COMPLETED
Enrollment: 18
Start: 2010-06-01
Primary completion: 2016-09-01
Lead sponsor: University of Chicago
Conditions: Type 2 Diabetes; Sleep Disordered Breathing
Interventions: DRUG:Exenatide; DRUG:Placebo
Results posted: TRUE
Individual participant data sharing: NO

Registered primary outcomes

Non-REM Slow Wave Sleep [baseline and after 6 weeks of treatment]
Total Amount of Slow Wave Activity [baseline and after 6 weeks of treatment]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.